Business Context and Reporting Period
Company: Inmune Bio, Inc. (INMB)
Filing Type: Form 8-K (Current Report)
Date of Report: March 26, 2024
Reporting Period Context: The filing announces an upcoming conference call to discuss results for the fourth quarter ended December 31, 2023, and provide a corporate update.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This 8-K serves solely as a notification of an upcoming event to discuss these metrics.
Material Changes
No material financial changes or operational updates are detailed within this specific filing. The document references a press release (Exhibit 99.1) containing the announcement but does not include the financial data itself.
Guidance, Outlook, and Management Commentary
- Upcoming Event: A conference call is scheduled for Thursday, March 28, 2024, at 4:30 PM Eastern Time.
- Discussion Topics: Fourth quarter 2023 results and a corporate update.
- Emerging Growth Company Status: The registrant is identified as an emerging growth company.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit 99.1 for preliminary financial highlights.
- Confirm the date and time of the conference call (March 28, 2024, 4:30 PM ET) to access management commentary.
- Review the subsequent 10-Q or 10-K filing for the audited or reviewed financial statements for the period ended December 31, 2023.